Janet Woodcock and Big Pharma

Selected healthcare news for the person - Janet Woodcock, and the healthcare topic - Big Pharma We have a small number of shared news items for this connection to-date.

Please provide a valid email address.

Selected Headlines

Date Headline (link) Source Relevant Snippet
3/22/2021 Biden FDA nominee faces Democratic opposition over Big Pharma and opioids Washington Examiner A cting Food and Drug Administration head Janet Woodcock is a leading contender for nomination as permanent commissioner of the agency but faces opposition from Democrats for her ties to the major drug companies responsible ... not quelled Democratic concerns that Woodcock is too friendly with Big Pharma. Pharmaceutical companies provide significant financial backing for those organizations, having donated more than $116 million to patient advocacy groups in a single year ...
3/22/2021 The Examiner - Trump slams Mayorkas ... Big Pharma and opioids Acting Food and Drug Administration head Janet Woodcock is a leading contender for nomination as permanent commissioner of the agency but faces opposition from Democrats for her ties to the major drug companies responsible for developing highly addictive opioid painkillers. 2021 could see strong economy coupled with emergency monetary and fiscal policies The United States could look like a booming economy by the end of the ...
2/12/2021 FDA commissioner race tests big pharma's sway; Hassan opposes lackeys of opioid profiteers FDA commissioner race tests big pharma‚Aos sway; Hassan opposes lackeys of opioid profiteers By Emily Kopp CQ Roll Call Feb 12, 2021 SaveWASHINGTON ‚Ai A tug of war over who should lead the ... the pharmaceutical industry.The two front-runners are acting Commissioner Janet Woodcock, an FDA official of 37 years viewed as open to approving therapies through accelerated pathways, and Joshua Sharfstein, a public health academic who ...
3/19/2020 Coronavirus: Trump aide Peter Navarro slams Big Pharma CNBC ... House National Trade Council Director Peter Navarro Chip Somodevilla Getty Images One of President Donald Trump's leading trade advisors slammed Big Pharma's attempts to lobby against an executive order he is preparing to push companies ... including 13% in China, according to October congressional testimony by Janet Woodcock, director of the Food and Drug Administration's Center for Drug Evaluation and Research. The executive order Navarro is planning will streamline regulatory approvals ...